Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Zylox-Tonbridge Medical Technology Co., Ltd. Class H ( (HK:2190) ) has provided an update.
Zylox-Tonbridge Medical Technology Co., Ltd. plans to amend its 2021 H Share Award and Trust Scheme by expanding the maximum number of H shares that can be granted or purchased under the plan to 10% of the company’s issued share capital, excluding treasury shares, as of approval at the 2025 annual general meeting. The company also seeks to extend the scheme’s validity for 10 years from that approval date, aiming to broaden long-term equity incentives for talent, subject to shareholder endorsement at a forthcoming general meeting despite the changes not requiring approval under Hong Kong listing rules.
A shareholder circular detailing the proposed changes and the upcoming annual general meeting will be provided in due course, signaling a continued commitment to share-based incentives within the existing regulatory framework. The amendments, if approved, would enhance the scale and duration of the company’s share incentive program, potentially strengthening employee alignment with shareholder interests and supporting Zylox-Tonbridge’s competitiveness in attracting and retaining key staff.
The most recent analyst rating on (HK:2190) stock is a Hold with a HK$27.00 price target. To see the full list of analyst forecasts on Zylox-Tonbridge Medical Technology Co., Ltd. Class H stock, see the HK:2190 Stock Forecast page.
More about Zylox-Tonbridge Medical Technology Co., Ltd. Class H
Zylox-Tonbridge Medical Technology Co., Ltd. is a PRC-incorporated medical technology company listed in Hong Kong, focused on developing and commercializing medical products and solutions. The company uses an H share award and trust scheme funded by on-market purchases of its existing H shares to incentivize and retain eligible participants.
Average Trading Volume: 726,257
Technical Sentiment Signal: Buy
Current Market Cap: HK$8B
For detailed information about 2190 stock, go to TipRanks’ Stock Analysis page.